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Background: HSP90 protects the cells from heat stress and facilitates protein maturation and stability. The full
genome sequences of piroplasms contain two putative HSP90 proteins, which are yet uncharacterized. To this end,
the two putative HSP90 proteins of Babesia orientalis were identified and characterized by molecular and in silico
methods.
Methods: The two putative proteins in B. orientalis genome showing homology with putative HSP90 of other
piroplasms were cloned and sequenced. A computational analysis was carried out to predict the antigenic
determinants, structure and function of these proteins. The interactions of two HSP90 isoforms with respective
inhibitors were also examined through docking analysis.
Results: The length of BoHSP90-A gene (amplified from gDNA) was 2706 bp with one intron from position 997 to
1299 bp. This gene amplified from cDNA corresponded to full length CDS with an open reading frame (ORF) of
2403 bp encoding a 800 amino acid (AA) polypeptide with a predicted size of 91.02 kDa. The HSP90-B gene was
intronless with an ORF of 2349 bp, and predicted polypeptide comprised of 797 AA with a size of 90.59 kDa. The
AA sequences of these two proteins of B. orientalis were the most identical to those of B. bovis. The BoHSP90-A and
BoHSP90-B were recognized as 90 kDa in the parasite lysate by the rabbit antisera raised against the recombinant
BoHSP90 proteins. The anti-B. orientalis buffalo serum reacted with the rBoHSP90s expressed in E. coli, indicating that
these proteins might be secreted by the parasite before entry into host cells. The overall structure and functional
analyses showed several domains involved in ATPase activity, client protein binding and HSP90 dimerization. Likewise,
several HSP90 inhibitors showed binding to ATP binding pockets of BoHSP90-A and BoHSP90-B, as observed through
protein structure-ligand interaction analysis.
Conclusions: The two putative HSP90 proteins in B. orientalis were recognized as 90 kDa. The rBoHSP90-A and
rBoHSP90-B were reacted with the B. orientalis infected buffalo serum. The computational structure and functional
analyses revealed that these two proteins may have chaperonic activity. The protein structure-ligand interaction analyses
indicated that these two proteins had many drug target sites.
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Babesia orientalis is a tick-borne intraerythrocytic proto-
zoan parasite, which was identified as a new species
in 1997 based on morphology, transmission and
pathogenicity [1,2]. It was the phylogenetic analysis of
B. orientalis based on 18S rRNA gene and Mitochondrial
genome sequences that confirmed its taxonomic standing
[3,4]. This pathogen is transmitted by Rhipicephalus
haemaphysaloides and is known to cause babesiosis in
water buffaloes [1,2]. The disease is endemic to most
parts of central and southern China with reported cases of
mortality [1,2,5]. The disease is mainly characterized by
anemia, fever, icterus, hemoglobinuria and is often fatal in
immunodeficient animals [3,4].
Heat shock protein 90 (HSP90) is one of the most
abundant proteins in many cells and protects them from
heat and oxidative stress by stabilizing proteins [6,7]. It
also aids in the elimination of denatured and aggregated
proteins that cannot function properly and may cause lethal
damage to cells [8]. HSP90 is a key element of chaperone
machinery under non-heat stress conditions and facilitates
protein trafficking, maturation and stability [9]. The multi-
chaperone complexes formed by HSP90 and co-chaperones
determine the conformation of newly synthesized proteins,
known as “client proteins” [10].
An 82 kDa protein of the HSP90 family has recently
been identified in many protozoan parasites [11-15].
Several studies demonstrated that this HSP90 molecule
is secreted in the milieu by extracellular infective forms
of protozoa and is associated with the entry of parasite
into the host cells [13,16]. Nevertheless, experimental
evidence suggested that this molecule, localized both in
cytosol and nucleus, is an essential component for stage
differentiation and intracellular growth of many protozoans
[11,16-19]. It is interesting to note that the full genome
sequences of Babesia and Theileria also contain two HSP90
putative proteins, which have not been characterized yet
(Additional file 1). To this end, the present study was
conducted to identify and characterize the two novel
HSP90 proteins in B. orientalis, including BoHSP90-A
and BoHSP90-B. Their immunogenicity was assessed
by reacting recombinant BoHSP90 proteins with anti-B.
orientalis buffalo serum. The structure and functional
analyses were performed through homology modeling.
Various HSP90 inhibitors showing ligand interactions with
BoHSP90-A and BoHSP90-B were identified through
computer-based drug design.
Methods
In silico identification of two HSP90-like proteins of B.
orientalis
The two putative B. orientalis HSP90 proteins were given
the names “BoHSP90-A and BoHSP90-B”. The BoHSP90-A
and BoHSP90-B were identified in silico from the fullgenome sequence of B. orientalis (unpublished sequence).
Two putative HSP90 nucleotide sequences of B. bovis
including BbHSP90 (XM_001611817.1) and BbHSP90
putative (XM_001610712.1) were obtained from GenBank
using a BLAST search. The two B. bovis HSP90 sequences
were aligned with B. orientalis genome sequence to
find BoHSP90-A and BoHSP90-B gene sequences.
The resulting sequences were confirmed through BLASTn
search and multiple sequence alignment with all putative
HSP90 genes of other apicomplexan parasites available in
the GenBank.Parasites and animals
Two water buffaloes of ≥2 years old were purchased
from a Babesia free area and used for the preparation of
anti-B. orientalis serum. They were confirmed as clean
for B. orientalis through reverse line blot hybridization
[20]. The parasite was cultured in splenectomized buffalo
by inoculating 4 ml of B. orientalis infected blood with 1%
parasitaemia (Wuhan strain) according to He et al. [4].
The blood was collected everyday to monitor the parasit-
aemia until it reached 3%. The immune serum against B.
orientalis from infected buffaloes was also isolated and
stored at −20°C until further use.
Six Japanese white female rabbits (specific pathogen
free, SPF) were used for the preparation of immune
serum against rBoHSP90-A and rBoHSP90-B.
The animals used in all the experiments were housed
and treated in accordance with the stipulated rules for
the regulation of administration of affairs concerning
laboratory animals of P.R. China. The animal protocols
for these experiments were approved by Standing
Committee of Hubei People’s Congress, P. R. China,
Laboratory Animals Research Centre of Hubei province
and the Ethics Committee of Huazhong Agricultural
University (Permit number: 4200696657).Extraction of nucleic acids and preparation of cDNA
The blood samples from the jugular veins of experimen-
tally infected buffaloes with 3% parasitaemia were collected
in BD Vacutainer® tubes containing EDTA (Qingdao
Pharmacypro Co., Ltd.) for the extraction of DNA
and RNA. The leukocytes were removed from the
blood using Plasmodipur filters (EuroProxima, Arnhem,
the Netherlands) and total RNA was extracted from 250 μl
of RBCs using TRIzol® RNA extraction kit (Invitrogen,
USA) according to the manufacturer’s instruction. RNA
samples were treated with DNase I (Invitrogen, USA);
RNase inhibitor (RNaseOUT™ Recombinant Ribonuclease
Inhibitor, Invitrogen, USA) was added and then the
RNA was reverse transcribed using FastQuant® RT Kit
(TIANGEN Biotech (Beijing) Co., Ltd.) according to
the manufacturer’s instruction.
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infected blood using QIAamp® DNA mini Kit (Qiagen,
Hilden, Germany) following the manufacturer’s instructions
and stored at −20 °C till further use.
Amplification, cloning and sequencing of BoHSP90-A and
BoHSP90-B genes
The oligonucleotide primers for the amplification of
BoHSP90-A and BoHSP90-B genes were designed
from full length sequences, as obtained from the genome
sequence of B. orientalis through in silico method (Table 1).
The two BoHSP90 genes were amplified from gDNA using
Ex Taq® Hot Start master mix (TaKaRa Biotechnology,
Dalian, China). The thermalcycling parameters for both
genes included: the activation of Taq polymerase at 95°C
for 10 min followed by 35 cycles of denaturation at 95°C
for 1 min, annealing at 60°C for 1 min and extension
at 72°C for 3 min, and a final extension of 10 min at 72°C.
The RNAse free water was used as a negative control.
The resulting PCR products were electrophoresed using
2% ethidium bromide stained agarose gel and purified using
the Universal DNA Purification Kit (TIANGEN Biotech
(Beijing) Co., Ltd.) according to the manufacturer’s
instructions. The purified products were cloned intoTable 1 Oligonucleotide primers used for the
amplification and sequencing of Babesia orientalis
HSP90-A and HSP90-B genes
Primer Sequence (5′-3′) Remarks
BoHSP90-A gene
1HSP90-Fa ATGACGGCTGGGGGAGCTCTG Primers for
amplification of ORF
1HSP90-R b TTAAGCAGCCACAGTGGGTGATTGC









2HSP90-Fa ATGAAGCGGTCCATATTTTTC Primers for
amplification of ORF
2HSP90-R b TCAAAGTTCGTCATTGACGG








Superscript a and b are indicating sense and antisense primers, respectively.pMD19-T vector (TaKaRa Biotechnology (Dalian), China)
and positive plasmids were sequenced using Dye
Terminator Cycle Sequencing ready reaction in ABI
PRISM 377 DNA sequencer with v2.1.1 software according
to the manufacturer’s instructions. Table 1 shows the
vector primers and custom synthesized primers used for
the sequencing of BoHSP90-A and BoHSP90-B genes.
In order to determine the presence of introns in
BoHSP90-A and BoHSP90-B genes, the ORF of genes
were amplified from cDNA and sequenced using the
protocol described above.
Sequence structure, function and motifs prediction
The obtained sequences for BoHSP90-A and BoHSP90-B
genes were assembled in the Staden Package (version 1.6.0
for Windows) [21-23] and submitted to GenBank with
accession numbers KF379584-KF379585. The predicted
AA sequences for BoHSP90-A and BoHSP90-B were
obtained by translating ORFs in ExPASy translation
tool (http://web.expasy.org/translate/). The predicted
structures of BoHSP90-A and BoHSP90-B were prepared
using the I-TASSER Standalone Package (Version 2.1)
[24] and edited in the Strap software [25]. The
secondary structures and motifs of proteins were pre-
dicted by comparing with crystal structures of HSP90 of
yeast (PDB code: 2cg9) [10,26] at the SWISS-MODEL
server [27].
Several HSP90 inhibitors, that can alter the biological
activity of BoHSP90-A and BoHSP90-B, were predicted
at ProFunc server [28]. The structures of inhibitors
complexed with proteins were downloaded from RCSB
Protein Data Bank. The template IDs of structures of
inhibitors and PDB codes of the complexed proteins
have been given in Table 2. The schematic diagrams
of the interaction between BoHSP90 proteins and ligands
(inhibitors) were prepared and edited in the LIGPLOT+
software (version v.1.4.5) [29].
Various antigenic peptides of BoHSP90-A and BoHSP90-B
were determined using the Protean program of Lasergene®
software package, version 10 (DNASTAR, Madison,
WI, USA). The average antigenic propensity of BoHSP90-A
and BoHSP90-B was predicted based on the table of
experimentally known epitopes [30].
Recombinant expression and purification of BoHSP90-A
and BoHSP90-B
The ORFs of BoHSP90-A and BoHSP90-B were amplified
from the cDNA and subcloned into the pET-32a vector
using the EcoRI and XhoI restriction sites. The resulting
plasmids pET-32a/BoHSP90-A and pET-32a/BoHSP90-B
were transformed into the E. coli BL21™ (DE3) strain
(Transgene, China) using the standard method. The
plasmids from bacterial cells at each step were extracted
using QIAGEN Plasmid Mini Kit (Qiagen, Hilden,
Table 2 Interaction of Babesia orientalis HSP90-A and B isoforms with inhibitors using docking analysis
Name Protein showing
interaction
Template ID PDB code
Geldanamycin BoHSP90-A, BoHSP90-B Gmy1 2exl
Radamide BoHSP90-A, BoHSP90-B Rda1001 2gfd
Redicicol BoHSP90-A, BoHSP90-B Rdc301 1u0z
Dihydroxyphenylpyrazoles BoHSP90-A, BoHSP90-B 4BC401 1yc1
PU8(8-(2-chloro-3,4,5-trimethoxy-benzyl)-2-fluoro-9-pent-4-ylnyl-9 h-purin-6-ylamine) BoHSP90-B PU11224 1uyf
PU11 (8-(2,5-dimethoxy-benzyl)-2-fluoro-9- pent-9 h-purin-6-ylamine) BoHSP90-A Puz1224 1uyi
1-(2-phenol)-2-naphthol BoHSP90-A, BoHSP90-B AB41226 2bz5
3,4-diaryl pyrazole resorcinol (CCT018159) BoHSP90-A, BoHSP90-B Ct51224 2bt0
4-amino derivative of 3,4-diaryl pyrazole (4-chloro-6-(4-piperazin-1-yl-1 h-pyrazol-3-yl)-
benzene-1,2-diol)
BoHSP90-B 4BH1224 2ccs
The template IDs are the identification numbers of inhibitors in RCSB Protein Data Bank. The proteins complexed with the inhibitors are indicated by PBD codes.
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tion and sequencing analysis in order to verify successful
cloning and the orientation of genes in the vector.
The proteins were expressed in E. coli by inducing
with 1 mM isopropyl β-D-thiogalactoside (IPTG). The
rBoHSP90-A and rBoHSP90-B were expressed as His-
fusion proteins and their expressions were monitored
through SDS-PAGE. The uninduced plasmids pET-
32a/BoHSP90-A and pET-32a/BoHSP90-B and IPTG
induced empty vector (pET-32a) were used as negative
controls (Figure 1).
The rBoHSP90-A and rBoHSP90-B were expressed in
the insoluble-fraction of E. coli and were purified using
HiTrap TALON crude (GE Healthcare, Sweden). The
affinity chromatography was performed according to the
manufacturer’s instructions. The quantities of recombinant
proteins were measured by BCA protein assay kit
(Beyotime Institute of Biotechnology, China) according to
the manufacturer’s instructions.Figure 1 Purification of the recombinant proteins from E. coli using S
weight marker, lane 1 lysate of IPTG induced empty vector (pET-32a), 2 lysa
plasmid, 4 purified rBoHSP90-A. (b) Purification of rBoHSP90-B. Lane M pre-
vector (pET-32a), 2 lysate of uninduced plasmid pET-32a/BoHSP90-B, 3 lysat
bands are indicated by arrows.Production of anti-rBoHSP90-A and anti-rBoHSP90-B
immune serum
Six Japanese white female rabbits (SPF) weighing 2 kg
were divided into 2 groups (A and B). Two rabbits in
each group were immunized subcutaneously with 500 μg
of rBoHSP90-A and rBoHSP90-B, respectively, emulsified
in equal amounts of Freund’s complete adjuvant (Sigma,
USA). One untreated rabbit in groups A and B served as a
negative control. The same amounts of antigens emulsified
in Freund’s incomplete adjuvant (Sigma, USA) were
injected subcutaneously into the immunized rabbits on
days 14, 21 and 28. Two weeks after the last immunization,
sera from the immunized rabbits were collected and stored
at −20°C until further investigation.
SDS-PAGE and western blotting
For the preparation of parasite lysate from infected
buffalo blood, the mononuclear cells from the blood
(3% parasitaemia) were removed using HISTOPAQUE®-1077DS-PAGE. (a) Purification of rBoHSP90-A. Lane M pre-stained molecular
te of uninduced plasmid pET-32a/BoHSP90-A, 3 lysate of IPTG induced
stained molecular weight marker, lane 1 lysate of IPTG induced empty
e of IPTG induced plasmid, 4 purified rBoHSP90-B. The corresponding
Figure 2 The PCR amplification of HSP90-A and HSP90-B genes
from gDNA and cDNA of B. orientalis. (a) PCR products of BoHSP90-A
gene. Lane M marker, lane 1 amplification from cDNA (2403 bp), 2
amplification from gDNA (2706 bp), 3 negative control. (b) PCR products
of BoHSP90-B gene. Lane M marker, lane 1 amplification from cDNA
(2394 bp), 2 amplification from gDNA (2394 bp), 3 negative control.
Khan et al. Parasites & Vectors 2014, 7:293 Page 5 of 15
http://www.parasitesandvectors.com/content/7/1/293(Sigma, USA) according to the manufacturer’s instruc-
tions. The parasite lystae was then prepared by following
the steps described elsewhere [31]. To identify native
HSP90-A and HSP90-B in B. orientalis, the parasite lysate
was subjected to 12% SDS-PAGE using the standard
method followed by electroblotting onto a nitrocellulose
membrane (Millipore, USA). The membranes were then
probed with rabbit antisera from groups A (1:500 dilution)
and B (1:500 dilution) separately and incubated overnight
at 4°C. The membranes were washed 5 times with
TBST and incubated with secondary antibodies (1:2000,
HRP labeled goat anti-rabbit IgG, Beyotime Institute of
Biotechnology) for 2 hours at room temperature. After
washing, the protein bands on membranes were visualized
using DAB method (ZSGB-BIO, China). The lysate of un-
infected buffalo erythrocytes and the serum of untreated
rabbits were used as controls.
In order to investigate the presence of antibodies in
buffalo serum against BoHSP90-A and BoHSP90-B, the
western blot analysis was carried out as mentioned
above, but using the recombinant proteins and buffalo
sera. Briefly, the rBoHSP90-A and rBoHSP90-B expressed
in E. coli were separated on 12% SDS-PAGE. The blotted
membranes were incubated with anti-B. orientalis
buffalo immune serum (1:500) and then with secondary
antibodies (1:2000, HRP labeled goat anti-bovine IgG,
Sigma, USA). The serum from normal buffalo was used as
a negative control. For positive control, the rBoHSP90-A
and rBoHSP90-B were probed with anti-His tag antibodies
(primary antibodies, 1:5000, EarthOx, LLC, USA) and
then with secondary antibodies (1:2000, HRP labeled goat
anti-mouse IgG, Beyotime Institute of Biotechnology,
China). The antibodies at each step in the experiment
were diluted with TBST containing 5% skimmed milk.
Results
Molecular characterization and sequence analysis
The HSP90-A gene of B. orientalis was amplified from
both gDNA and cDNA by PCR using 1HSP90-F and
1HSP90-R primers, designed based on in silico BLAST
search on B. orientalis genome sequences (Table 1). The
amplified sequence of BoHSP90-A gene from gDNA was
2706 bp long, while, the amplicon from cDNA was 2403 bp
long (Figure 2a) with complete ORF. The nucleotide
sequence of BoHSP90-A gene amplified from gDNA
showed the presence of one intron from position 997 to
1299 bp. The encoded polypeptide comprised of 800 AA
residues with a predicted size of 91.02 kDa, as determined
through a computer-based molecular weight calculator [32].
The HSP90-B gene of B. orientalis was amplified by
PCR using 2HSP90-F and 2HSP90-R primers. The PCR
amplified products from both templates were the same
size (Figure 2b) and length (2394 bp), indicating no
intron. The ORF encoded a polypeptide of 797 AA with asize of 90.59 kDa. The protein IDs of BoHSP90-A and
BoHSP90-B in GenBank are AGY56137 and AGY56138.
The percent identity between the AA sequences of
the two BoHSP90 was 27.9%. The AA sequences of
BoHSP90-A and BoHSP90-B were most identical to
those of B. bovis HSP90 (XP_001611867.1) and HSP90
putative (XP_001610762.1) genes with an identity of
86.6% and 82.2%, respectively. The percent identities
between HSP90-A and HSP90-B AA sequences of B.
orientalis and other piroplasms have been shown in
the Additional file 1. The AA sequence of BoHSP90-A
was well conserved in other piroplasms, showing 55-86%
identity. However, BoHSP90-B AA sequence was 35-82%
identical to HSP90-B sequences of other piroplasms.Predicted structure and functional analysis
The predicted 3D structures of BoHSP90-A and BoHSP90-B
were modeled through homology-modeling using the
crystal structure of HSP90 of yeast (PDB code: 2cg9)
[26] as a template. As shown in the Figure 3, both
structures had binding sites for ATP, further confirming
that these two putative proteins in B. orientalis belong to
HSP90 family. Although, the AA sequences of BoHSP90-A
and BoHSP90-B are not well conserved (27.9% identical);
however, their predicted domain structures appeared
to be similar (Figure 4). The predicted structure of
BoHSP90-A and BoHSP90-B comprised of three do-
mains including N-terminal, middle domain (Ribosomal
protein S5 domain 2-like superfamily) and C-terminal
domain (Figure 4a and b).
Figure 3 Structural modeling of B. orientalis HSP90-A and B isoforms. (a) cartoon rainbow (blue-red) of BoHSP90-A from N to C-terminal
indicating the binding site for ATP and conserved Arg at position 482 in catalytic loop (red). (b) the structure of BoHSP90-B showing ATP binding
site and conserved Arg at position 421 in catalytic loop (red).
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are well conserved in HSP90-A and HSP90-B of other
piroplasms, respectively (Additional files 2 and 3). The
N-terminal domains of the 2 putative B. orientalis HSP90s
contained the ATP binding sites and the residues essential
for ATPase activity equivalent to HATPase_c domain in
MutL and type II toposimerases (Figure 5). The conserved
GxxGxG motif, essential for ATP binding, in BoHSP90-A
was from 237–242 residues (Figure 5b). These residues in-
cluding Gly237, Gln238, Phe239, Gly240, Val241, Gly242
in BoHSP90-A were wrapping around β and γ phosphatesFigure 4 Schematic illustrations of the predicted domains of B. orientof the ATP molecule. Among these, the residues Gly237
and Phe239 made hydrophobic interactions while the
other residues along with Ser215 and Arg482 interacted
with the two phosphates of the ATP through hydrogen
bonds. The residues Phe243, Asn208 and Thr297 were in-
volved in the interaction of hydrogen bonds with α phos-
phate, ribose sugar and adenine ring, respectively. The
residues in the distal part of N-terminus were involved in
hydrophobic interactions (Figure 5b).
In BoHSP90-B, the residues wrapping around β and γ
phosphates of the ATP molecule (GxxGxG motif ) werealis HSP90-A (a) and HSP90-B (b).
Figure 5 Schematic interactions of ATP with the N-terminal domains of B. orientalis HSP90-A and B isoforms. (a) and (c) close-up of ATP
molecules bound to N-terminal domains of BoHSP90-A and BoHSP90-B, respectively. (b) and (d) biochemical interactions of ATP with the residues
of BoHSP90-A and B isoforms, respectively. For key items, see Figure 7.
Khan et al. Parasites & Vectors 2014, 7:293 Page 7 of 15
http://www.parasitesandvectors.com/content/7/1/293from 206 to 211, including Gly206, Gln207, Phe208,
Gly209, Val210 and Gly211 (Figure 5d). Similar to
BoHSP90-A, the residues Gly206 and Phe208 were
involved in the hydrophobic interaction and Ser186 and
Arg421 interacted through hydrogen bonds with the β
and γ phosphates of ATP molecule, respectively. The α
phosphate and ribose sugar of ATP molecule interacted
with Phe212 and Asn179 residues of N-terminus of
BoHSP90-B, respectively. In contrast, no residue of
N-terminal domain of BoHSP90-B was involved in
the interaction with adenine ring of the ATP molecule.
However, the residues Ala129, Gly170, Met171 and
Gly187 in the distal part of N-terminus were involved
in the hydrophobic interactions with the adenine ring
(Figure 5d). The residues in the GxxGxG motif inBoHSP90-A and BoHSP90-B are highly conserved in
yeast HSP90 (residues 118–123) [10].
Topologically similar to the middle domains of MutL,
DNA gyrase B (Gyr B) and HSP90 proteins, the middle
domains of BoHSP90-A and BoHSP90-B comprised of
three distinct subdomains including a large αβα sandwich
at N-terminus of middle domain, a α3 helical coil in the
middle and a small αβα sandwich at the C-terminus
(Figure 6a and b). All these subdomains contained essential
residues for client protein binding and ATP hydrolysis.
These results indicated that the middle domains of
BoHSP90-A and BoHSP90-B belong to the ribosomal
protein S5 domain 2-like superfamily.
The hydrophobic residues in the middle domain of
BoHSP90-A are on or near the Src loop (residues 427–442).
Figure 6 The middle and C-terminal domains of B. orientalis HSP90-A and B isoforms. (a) and (b) middle domain of BoHSP90-A and
BoHSP90-B, respectively, showing three subdomains. (c) Dimerization interface between C-terminal domains of two BoHSP90-A molecules formed
by 656–785 residues. (d) Dimeric C-terminal domain of BoHSP90-B formed by 621–748 residues.
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327–340 in yeast) are not well conserved in BoHSP90-A;
however, the pattern of hydrophobic and hydrophilic
residues is the same. Similarly, the residues 368–381
of BoHSP90-B formed a distinct Src loop, containing a
combination of hydrophobic and hydrophilic residues.
The middle of these two proteins also comprised a
catalytic loop, which is essential for the hydrolysis of
ATP. This loop in the middle domain of BoHSP90-A
(residues 477–490) contains conserved Asn479, Arg482,
and Gln486 (Asn377, Arg380, and Gln384 in yeast). The
same residues in the catalytic loop in BoHSP90-B
(residues 416–429) are at position N418, R421 and
Q425, respectively. The catalytic loop in the middle
domains of BoHSP90-A and BoHSP90-B along with
conserved Arginine has been shown in Figure 3.
The extreme segment of the C-terminal domain of both
BoHSP90-A and BoHSP90-B proteins lack the MEEVD
motif, which is known to interact with tetratricopeptide
repeat (TPR) domains of co-chaperones in Eukaryotes[33,34]. However, the C-terminus of BoHSP90-A and
BoHSP90-B exhibited dimerization interface formed by
residues 656–785 and 621–748 (correspond to 749–674
in yeast), respectively. The dimeric C-terminal domains
of BoHSP90-A and BoHSP90-B have been presented
in Figure 6c and d.
HSP90 inhibitors
The inhibitors of BoHSP90-A and HSP90-B identified
through structure-based design include Geldanamycin
(GA), Radamide (RD), Radicicol (RC), dihydroxyphenyl-
pyrazoles, purine-based inhibitors (PU1, PU8, PU11),
4-amino derivatives (e.g. 4-chloro-6-(4-piperazin-1-yl-1
h-pyrazol-3-yl)-benzene-1,2-diol), 1-(2-phenol)-2-naphthol
compounds and 3,4-diarylpyrazole class (Table 2). All these
inhibitors exhibited binding to ATP binding pockets of the
N-terminal domains of BoHSP90-A and BoHSP90-B.
The GA-BoHSP90-A interaction analysis revealed that
the residues Lys219 and Ser257 made hydrogen bonds
with the methoxy group of ansa ring and ASP195 with the
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and Thr226 interacted with carbamate and methoxy
groups, respectively. A covalent bond was observed
between Thr260 and methyl group, Asn125 and meth-
oxy group and Asn179 and quinone. The residues forming
hydrophobic interactions with GA are indicated in
Figure 7a and Figure 8a.
In RD-BoHSP90-A complex, the residues Gly240 and
Asn208 interacted with quinone through hydrogen and
covalent bonds, respectively (Figure 7b). The residues of
BoHSP90-B interacting with the quinine of RD were
Asn179, Lys185 and Gly207 (Figure 8b). The residue
Asp195 of BoHSP90-A and Asp166 of BoHSP90-B made
hydrogen bonds with the resorcinol ring of RC. The resi-
dues Lys132 of BoHSP90-B interacted with ethylene oxide
group and Phe212 and Ile263 with the resorcinol ring of
RC through covalent bonds (Figure 7c and Figure 8c).
The pyrazole NH of dihydroxyphenylpyrazole formed
a hydrogen bond with the carbonyl of Ile198 of
BoHSP90-A. The carboxyl group of pyrazole ring made
a hydrogen bond with NH2 of Lys161 and CH3 of
Met200. The residue Ile299 made a hydrogen bond
with the hydroxyl group of the dihydroxyphenyl ring
(Figure 7d). In dihydroxyphenylpyrazole-BoHSP90-B
complex, the carbonyl of Val169 made a hydrogen
bond with NH of pyrazole, NH2 of Lys132 with the
carboxyl group of pyrazole ring, the amino group of
Asn179 with oxygen of benzodioxole ring and Phe212
made polar interactions with the dihydroxyphenyl ring
(Figure 8d).
Among the purine-based inhibitors, the compound 8 was
observed to be the most active, inhibiting the function of
human HSP90 [35]. The structure of BoHSP90-B showed
binding to PU8 as investigated through computer-based
drug design. The BoHSP90-B residues Lue176, Asn179 and
Leu180 interacted with the three methoxy groups of the
aromatic ring of PU8 through covalent bonds and hydrogen
bonds. A dipole interaction was observed between Fluorine
of 2-fluoro-adenine and oxygen of Val169 (Figure 8e). The
structure of BoHSP90-A showed binding to compound 11
of purine-based derivatives. The hydroxyl group of Thr297
made hydrogen bond with N2 of 2-fluoro-adenine and
oxygen of Ile198 made dipole interaction with Fluorine.
The C5 of 1-pentynyl of PU11 interacted with the sulfur
of Met200 through covalent bond (Figure 7e).
Among the derivatives of 1-(2-phenol)-2-naphthol
class, the structures of BoHSP90-A and BoHSP90-B
complexed with compound 11. In the complex between
BoHSP90-A and 1-(2-phenol)-2-naphthol, a hydrogen
bond was observed between the hydroxyl group of
naphthol and Asp195, and the hydroxyl group of phenol
ring and Thr184 (Figure 7f). In BoHSP90-B-1-(2-phenol)-
2-naphthol complex, a hydrogen bond was observed
between the hydroxyl group of Phenol ring and Val169.The nonpolar benzyl group of Phe212 made covalent bonds
with the benzene ring of the naphthol group (Figure 8f).
The analysis of interaction between BoHSP90-A and
3,4-diaryl pyrazole resorcinol (CCT018159) revealed that
the hydroxyl group of resorcinol made a hydrogen bond
with side-chain oxygen of Asp195, the amino group of
pyrazole with main-chain oxygen of Ile198 and the
methyl group of pyrazole with main-chain amino group of
Lys161 (Figure 7g). The interaction between BoHSP90-B
and 3,4-diaryl pyrazole resorcinol appeared to be the
same. The oxygen group of Asp166 and Val169 made
hydrogen bonds with the hydroxyl group of resorcinol and
the amino group of pyrazole, respectively. The amino
group of Asn125 also made a hydrogen bond with the
oxygen of 1,4-benzodioxane. The benzyl ring of Phe212
showed interaction with the ethyl group of resorcinol ring
(Figure 8g).
The 4-amino derivatives of 3,4-diaryl pyrazole class
inhibitor have also been discovered with higher efficacy
against HSP90 activity [36]. The structure of BoHSP90-B
showed interaction with a 4-amino derivative (4-chloro-
6-(4-piperazin-1-yl-1 h-pyrazol-3- yl)-benzene-1,2-diol).
However, the interactions made by the residues of
BoHSP90-B with 4-amino derivatives were the same as in
3,4-diaryl pyrazole interaction. Importantly, no interaction
between the residues of BoHSP90-B and piperazine group
was obvious except hydrophobic interactions by Asn125,
Met171 and Asn179 (Figure 8h).Antigenicity analysis
The antigenicity analysis revealed that the amino acid
sequences of both proteins contain potential antigenic
determinants. The predicted polypeptide of BoHSP90-A
has 27 antigenic regions with an average antigenic propen-
sity of 1.0250 (Additional file 4). The BoHSP90-B polypep-
tide contains 36 antigenic regions with an average antigenic
propensity of 1.0189 (Additional file 5).Identification of BoHSP90-A and BoHSP90-B
The ORF of BoHSP90-A and BoHSP90-B genes were
expressed as an about 111.02 kDa and 110.59 kDa in E. coli,
respectively (Figure 1). However, the controls including
uninduced plasmids (pET-32a/BoHSP90-A and pET-32a/
BoHSP90-B) and IPTG induced empty vector (pET-32a)
did not show any band of the expected size.
The native HSP90-A and HSP90-B in B. orientalis
were identified by reacting rabbit antisera with parasite
lysate. As shown in Figure 9a and b, the specific strong
bands corresponding to ~90 kDa proteins were obtained
in B. orientalis lysates through western blot analysis,
consistent with the predicted sizes from sequences. The
controls, including the parasite lysates reacted with nor-
mal rabbit serum and the lysates of normal buffalo
Figure 7 Schematic interactions of B. orientalis HSP90-A isoform with its inhibitors. (a) Geldanamycin, (b) Radamide, (c) Redicicol,
(d) Dihydroxyphenylpyrazoles, (e) Purine-based derivative (PU11), (f) 1-(2-phenol)-2-naphthol, (g) 3,4-diaryl pyrazole resorcinol (CCT018159).
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Figure 8 Schematic interactions of B. orientalis HSP90-B isoform with its inhibitors. (a) Geldanamycin, (b) Radamide, (c) Redicicol,
(d) Dihydroxyphenylpyrazoles, (e) Purine-based derivative (PU11), (f) 1-(2-phenol)-2-naphthol, (g) 3,4-diaryl pyrazole resorcinol (CCT018159),
(h) The 4-amino derivative of 3,4-diaryl pyrazole class.
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Figure 9 Identification of the two putative B. orientalis HSP90 proteins through western blot analysis. (a) and (b) the detection of
BoHSP90-A and BoHSP90-B in parasite lysate, respectively. Lanes M pre-stained molecular weight markers, lanes 1 parasite lysates incubated with
rabbit antisera against recombinant proteins, 2 parasite lysates incubated with serum of normal rabbit (negative controls), 3 lysates of normal
buffalo erythrocytes incubated with rabbit antisera against recombinant proteins, 4 lysates of normal buffalo erythrocytes incubated with serum
of normal rabbit (negative controls).
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rabbit serum did not show any band.
The sera from experimentally infected buffalo strongly
reacted with rBoHSP90-A (Figure 10a) and rBoHSP90-B
(Figure 10b) and recognized the specific bands of
111.02 kDa and 110.59 kDa, respectively. The bands of
the same size for rBoHSP90-A and rBoHSP90-B, were
recognized by anti-His tag antibodies (positive control).
However, no band was obvious when the recombinant
BoHSP90 proteins were reacted with the normal buffalo
serum.
Discussion
There are five functional isoforms of HSP90 in higher
eukaryotes including HSP90-α1, HSP90-α2, HSP90-β,
GRP-94 (Endoplasmin) and TNF Receptor-AssociatedFigure 10 Reactivity of B. orientalis recombinant HSP90 proteins with
(a) and (b) western blot analysis of rBoHSP90-A and rBoHSP90-B, respective
proteins reacted with buffalo immune serum, 2 recombinant proteins incu
proteins reacted with anti-His tag antibodies (positive controls). The arrowsProtein 1 (TRAP) [37]. In the present study, two novel
isoforms of BoHSP90 encoding HSP90-A and HSP90-B
were identified and characterized. Although, the analysis
of full genome sequences of Babesia and Theileria
revealed the presence of some HSP90 putative proteins,
however, this is the first report on the molecular
characterization of HSP90-A and HSP90-B in Babesia
species. The deduced AA sequences of HSP90-A and
HSP90-B of B. orientalis showed identity with those of
B. bovis, B. equi, Theileria parva, T. annulata and T.
orientalis. These findings indicated that the amplified
products from gDNA and cDNA were HSP90-A and
HSP90-B genes of B. orientalis.
The recognition of BoHSP90-A and BoHSP90-B
from parasite lysate further confirmed that these two
isoforms of HSP90 exist in B. orientalis as 90 kDa. Athe buffalo immune serum identified through immunoblotting.
ly. Lanes M pre-stained molecular weight markers, lanes 1 recombinant
bated with normal buffalo serum (negative controls), 3 recombinant
on the right are indicating corresponding bands.
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also been reported to contain a 82 kDa protein of HSP90
family including Leishmania donovani [11], Trypano-
soma cruzi [12], Toxoplasma gondii [13], Plasmodium
falciparum [14], Eimeria acervulina and E. tenella [15].
The structural analysis revealed that the BoHSP90-A
and BoHSP90-B has various components essential for the
chaperone activity. The residues essential for the ATP
binding in yeast HSP90 were observed to be highly con-
served in HSP90-A and HSP90-B of B. orientalis and
other piroplasms, indicating that their N-terminal domain
belongs to topoisomerase II superfamily. The BoHSP90-A
and BoHSP90-B contained a glycine-rich loop (GxxGxG)
within N-terminal, which wrapped around the phos-
phates of ATP molecule. The residues in the GxxGxG
motif in yeast HSP90, including Gly118, Gln119,
Phe120, Gly121, Val122, Gly123 [10], were conserved
in BoHSP90-A and BoHSP90-B. This structure also
overlays with the ATP binding domain of P. falciparum,
as demonstrated in the crystal structure of N-terminal
domain, in ATP bound state [38]. It has been observed
that the client protein is able to bind with the middle
domain of HSP90 without ATP in yeast, however, the
bound ATP gives ‘tense’ conformation to HSP90 dimer
which is required for the maturation of the client pro-
tein [10]. The presence of ATP binding domain along
with the GxxGxG motif suggests that the functioning
of BoHSP90-A and BoHSP90-B may depend on ATP
hydrolysis reaction.
The crystal structures of the middle domain of HSP90
in higher eukaryotes demonstrated that the combination
of hydrophobic and hydrophilic residues in the middle
domain (Src loop) provides a major site for client
protein binding [39]. Experimental evidence suggested
that the Arg 380 in yeast interacts with γ-phosphate of
an ATP molecule and is directly involved in ATP
hydrolysis, which is essential for the release of client
protein [10,39]. Consistent with the yeast middle domain
structure, the BoHSP90-A and BoHSP90-B consist of
the same pattern of hydrophobic and hydrophilic residues
in the middle domain, although the residues in this loop
in BoHSP90-A and BoHSP90-B are not well conserved.
However, the middle domain of BoHSP90s comprises the
conserved residues in the catalytic loop. Experimental
evidence suggests that the catalytic loop in the middle
domain of HSP90 in yeast (residues 375–388) is essential
for the ATPase activity [10].
Unlike other known HSP90 structures, the C-terminal
segments of two isoforms of B. orientalis HSP90 lack
MEEVD motif, although comprising dimerization interface.
The other charged domain at the extreme C-terminous
segment of BoHSP90-A and BoHSP90-B may play a signifi-
cant role in interaction with cochaperones. Alternatively,
they may adopt a different mechanism of organizingHSP90 chaperone complex. Interestingly, this segment
(MEEVD) is also lacking in the HSP90 HtpG of E. coli
[40], this molecule was observed to be capable of client
protein binding and release, as evident by crystallo-
graphic studies [41]. Alternatively, the C-terminal seg-
ment of 82 kDa homologue (HSP90) in apicomplexans
contains ~30 residues ending in MEEVD motif [13,14]. The
predicted structure analysis revealed that the BoHSP90-A
and BoHSP90-B contain numerous domains and residues,
essential for ATPase and chaperone activity. Further
crystallographic studies are required to better under-
stand the conformation of the bound ATP, client pro-
teins and co-chaperones in HSP90 chaperone complex
in B. orientalis.
A range of HSP90 inhibitors showed binding affinity
with ATP binding pocket of BoHSP90-A and BoHSP90-B.
Experimental evidence suggested that these inhibitors
significantly altered the function of HSP90 in humans and
have been used as anticancer drugs [42,43]. Recently,
some of these ligands were used to determine their effects
on parasite growth. On the other hand, the inhibition of
HSP90 activity by these ligands also facilitated in exploring
their function in cellular transformations during the
parasite life cycle [12]. Experimental evidence suggested
that the inhibition of HSP90 in protozoans significantly
altered the entry of parasite into host cells and intra-
cellular growth. GA treatment to the RH tachyzoites
of T. gondii blocked the entry of tachyzoites into the vero
cells by 75% within 4 h and significantly retarded the
intracellular growth [13]. The inhibition of stage differen-
tiation from bradyzoite to tachyzoite stage in T. gondii
by GA is also evident [44]. Similarly, the inactivation
of HSP90 by GA and RC with different sensitivities in
E. tenella, L. donovani, P. falciparum,T. cruzi,T. brucei, and
T. evansi has been proven [12,16-19,45]. Likewise,
ATP-competitive inhibition of BoHSP90-A and BoHSP90-B
may also help in investigating their roles in the invasion
of parasite into the host cells and intracellular growth.
The present results also provided a base line to test the
effect of other HSP90 inhibitors on the function of HSP90
in apicomplexan parasites and to investigate their effect
on the parasite life cycle and biology.
Surprisingly, the recombinant BoHSP90-A and BoHSP90-
B were recognized by buffalo immune serum, indicating
that these proteins might be secreted by parasites before
the entry into host cells and they may have a significant
role in the functional conformation of molecules important
for invasion of sporozoites or merozoites. Likewise, the
HSP70 in B. orientalis, involved in multi-chaperone
complex in eukaryotes [46], was also recognized by
buffalo immune serum [47]. The parasites during inva-
sion are exposed to protective immunity and the envir-
onmental stress. HSP90 may play an important role in
the establishment and development of these organisms
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have been previously detected in excretory/secretary
antigens [13,16]. On the other side, the presence of
antibodies against BoHSP90-A and BoHSP90-B in buf-
falo immune serum also indicates that these proteins may
have potential antigenic sites recognized by the im-
mune system of the host. Since, the antigenic analysis re-
vealed the presence of potential antigenic peptides in both
isoforms of BoHSP90 with an average antigenic pro-
pensity of 1, suggesting that these molecules are po-
tential candidates for developing a subunit vaccine.Conclusions
The antibodies raised against recombinant BoHSP90
proteins detected these proteins in the parasite lysate as
90 kDa. The rBoHSP90-A and rBoHSP90-B were recog-
nized by the anti-B. orientalis buffalo immune serum.
The antigenicity analysis indicated that these molecules
may have potential antigenic determinants for develop-
ing a subunit vaccine. The predicted secondary structure
analysis of BoHSP90-A and BoHSP90-B revealed the
presence of all domains involved in chaperonic activity,
including ATP binding pocket in N-terminal domain, Src
and catalytic loop in middle domain and dimerization
interface in C-terminal domain. Several HSP90 inhibi-
tors showed interaction with ATP binding pocket of
BoHSP90-A and BoHSP90-B proteins. The lack of
in vitro culture of Babesia orientalis was a limitation
in determining the function of these proteins in parasite
biology. Future experimental studies are needed to
determine their function in parasite biology and their
role in the invasion of parasite into host cells.Additional files
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